Clinical Trial Update: A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

View source ↗

Summary

This clinical trial status update describes a database study evaluating maralixibat (TAK-625) in participants with Alagille syndrome and progressive familial in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome
• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• Maralixibat (maralixibat)

Snippet

Sponsor: Takeda | Conditions: Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC) | Status: RECRUITING